Investor · Vancouver, British Columbia, Canada

Stephen R. Biggar

Open Stephen in the network graph →

Filings

7

SEC Form D

Connections

46

co-filers

Capital

$15.5M

across filings

Active

Mar 2011

to Jun 2024

Most-connected co-filers (46)

Robyn Samuels · Waltham, MA5 shared Mark Goldberg · SAN FRANCISCO, CA4 shared Felix J. Baker · Mountain View, CA4 shared Sanj K. Patel · Waltham, MA4 shared James Rogers · San Mateo, CA3 shared Thomas Malley · SAN DIEGO, CA3 shared Timothy Redmond · Aptos, CA3 shared Mark R. Retzloff · Boulder, CO3 shared Jaap Langenberg · Aptos, CA3 shared Christofer Schneider · San Mateo, CA3 shared Lou Salfi · San Mateo, CA3 shared David W. Dorman · Round Rock, TX2 shared Christopher Miglino · Los Angeles, CA2 shared Malcolm Casselle · Los Angeles, CA2 shared Erin Deruggiero · Los Angeles, CA2 shared E. S. Eskridge, Jr · Charlotte, NC2 shared Marc Savas · Los Angeles, CA2 shared Jeremy J. Burton · Round Rock, TX2 shared Richard W. Steel · LOS ANGELES, CA2 shared Ellen J. Kullman · Redwood City, CA2 shared Srini Akkaraju · Agoura Hills, CA2 shared Lyle K. Hohnke · Andover, MA2 shared James L. Tullis · Palm Beach Gardens, FL2 shared Hatch D. Graham · Redwood City, CA2 shared

Recent filings (7)

Notch Therapeutics, Inc.Jun 2024 · 19 co-filers$15.5M Notch Therapeutics, Inc.Jun 2024 · 19 co-filers$15.5M SYNAGEVA BIOPHARMA CORP.Mar 2011 · 11 co-filers$25.0M SYNAGEVA BIOPHARMA CORP.Mar 2011 · 11 co-filers$25.0M SYNAGEVA BIOPHARMA CORP.Aug 2010 · 13 co-filers$45.0M ENTEGRION INCOct 2009 · 17 co-filers$3.8M SYNAGEVA BIOPHARMA CORP.May 2009 · 13 co-filers$45.0M ENTEGRION INCMay 2009 · 18 co-filers$1.0M SYNAGEVA BIOPHARMA CORPApr 2009 · 13 co-filers$45.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Stephen in the interactive graph →